Skip to main content
. 2022 Oct 6;61(12):1677–1695. doi: 10.1007/s40262-022-01160-z

Table 1.

Detailed keyword search in each database

Database Keywords used for the search
PubMed

(Rivaroxaban) OR (BAY 59-7939) OR (anticoagulant)

AND

(Pharmacokinetics) OR (half-life) OR (concentration) OR (volume of distribution) OR (bioavailability) OR (clearance)

AND

(Obesity) OR (obese) OR (overweight) OR (extreme weight) OR (BMI) OR (body mass index)
Embase

‘rivaroxaban’/exp OR rivaroxaban OR (bay AND ’59 7939’) OR anticoagulant

AND

‘pharmacokinetics’/exp OR pharmacokinetics OR ‘half life’ OR ‘concentration’/exp OR concentration OR ‘volume of distribution’ OR ((‘volume’/exp OR volume) AND (‘distribution’/exp OR distribution)) OR bioavailability OR clearance

AND

‘obesity’/exp OR obesity OR obese OR ’overweight’/exp OR overweight OR ‘extreme weight’ OR (extreme AND (‘weight’/exp OR weight)) OR bmi OR (body AND mass AND index)
ScienceDirect

((Rivaroxaban) OR (BAY 59-7939))

AND

((Pharmacokinetics) OR (half-lfe) OR (concentration) OR (volume of distribution))

AND

((Obesity) OR (obese) OR (body mass index))
Cochrane Library

Rivaroxaban OR BAY 59 7939 OR anticoagulant

AND

Pharmacokinetics OR half-life OR concentration OR volume of distribution OR bioavailability OR clearance

AND

Obesity OR obese OR overweight OR extreme weight OR BMI OR body mass index